Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-09 4:19 pm Purchase | 2022-12-28 | 13D | KalVista Pharmaceuticals, Inc. KALV | TCG Crossover GP I, LLC | 3,408,081 9.900% | 3,408,081 (New Position) | Filing History |
| 2023-01-09 4:06 pm Purchase | 2022-12-28 | 13G | KalVista Pharmaceuticals, Inc. KALV | Venrock Healthcare Capital Partners III, L.P. | 2,916,667 8.600% | 2,916,667 (New Position) | Filing History |
| 2023-01-06 1:46 pm Purchase | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | BlackRock Inc. BLK | 1,572,421 4.600% | 67,801 (+4.51%) | Filing History |
| 2022-12-30 2:15 pm Purchase | 2022-12-28 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 3,238,859 9.500% | 1,666,667 (+106.01%) | Filing History |
| 2022-08-15 5:12 pm Sale | 2022-08-15 | 13G | KalVista Pharmaceuticals, Inc. KALV | RA Capital Management, L.P. | 0 0.000% | -1,930,322 (Position Closed) | Filing History |
| 2022-05-26 4:00 pm Purchase | 2022-05-16 | 13G | KalVista Pharmaceuticals, Inc. KALV | TANG CAPITAL PARTNERS LP | 1,400,000 5.700% | 1,400,000 (New Position) | Filing History |
| 2022-05-18 4:03 pm Purchase | 2022-05-09 | 13G | KalVista Pharmaceuticals, Inc. KALV | Great Point Partners, LLC | 1,280,000 5.220% | 1,280,000 (New Position) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Ikarian Capital, LLC | 36,576 0.200% | -1,027,385 (-96.56%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | RA Capital Management, L.P. | 1,930,322 7.900% | 530,833 (+37.93%) | Filing History |
| 2022-02-14 11:53 am Sale | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Eventide Asset Management, LLC | 138,821 0.600% | -1,541,179 (-91.74%) | Filing History |
| 2022-02-14 08:57 am Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Deep Track Capital, LP | 1,500,000 6.130% | 233,116 (+18.40%) | Filing History |
| 2022-02-11 5:28 pm Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Vivo Ventures VI LLC | 1,383,179 5.700% | 360,686 (+35.28%) | Filing History |
| 2022-02-11 5:03 pm Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT LLC | 1,746,300 7.100% | 449,848 (+34.70%) | Filing History |
| 2022-02-11 4:09 pm Sale | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Deerfield Mgmt, L.P. | 1,175,131 4.800% | -630,906 (-34.93%) | Filing History |
| 2022-02-10 5:11 pm Purchase | 2021-02-09 | 13D | KalVista Pharmaceuticals, Inc. KALV | Longwood Fund II L.P. | 7,801 0.030% | 7,801 (New Position) | Filing History |
| 2022-02-04 2:31 pm Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | FRANKLIN RESOURCES INC BEN | 1,252,142 5.100% | 1,252,142 (New Position) | Filing History |
| 2022-02-04 09:27 am Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Wellington Management Group LLP | 1,811,505 7.400% | 1,811,505 (New Position) | Filing History |
| 2022-01-31 5:49 pm Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | BlackRock Inc. BLK | 1,504,620 6.100% | 391,240 (+35.14%) | Filing History |
| 2022-01-31 5:00 pm Purchase | 2022-01-26 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 1,572,192 6.400% | 303,463 (+23.92%) | Filing History |
| 2021-12-30 4:33 pm Purchase | 2021-12-21 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 1,268,729 5.200% | 1,268,729 (New Position) | Filing History |